Saltar al contenido
Merck
  • VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.

VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.

Circulation research (2016-12-16)
Vijay Chaitanya Ganta, Min Choi, Anna Kutateladze, Brian H Annex
RESUMEN

Atherosclerotic-arterial occlusions decrease tissue perfusion causing ischemia to lower limbs in patients with peripheral arterial disease (PAD). Ischemia in muscle induces an angiogenic response, but the magnitude of this response is frequently inadequate to meet tissue perfusion requirements. Alternate splicing in the exon-8 of vascular endothelial growth factor (VEGF)-A results in production of proangiogenic VEGF The antiangiogenic VEGF In human PAD versus control muscle biopsies, VEGF Our results indicate that VEGF

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-phospho-VEGFR2 (pTyr1175) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-VEGFR1 (pTyr1333) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-phospho-VEGFR1 (pTyr1048) antibody produced in rabbit, affinity isolated antibody